Voluntis partners with Monarch. See the press release >

This press section is intended for journalists and investors for a professional use.

WHAT’S NEW
AT VOLUNTIS ?

ABOUT VOLUNTIS

Voluntis is dedicated to developing companion software that empowers patients to self-manage their chronic disease in collaboration with their medical team.

DOWNLOAD PRESS KIT

Working on a Voluntis story? We can help.

Press contact :
Amélie Janson
(617) 245-4125

  • Meet Insulia®

    What is companion software?

  • Tomorrowland: medical treatment in 2020

Meet Insulia®

What is companion software?

Tomorrowland: medical treatment in 2020

PRESS RELEASES

august 2018

Voluntis releases upgraded version of Insulia to improve user experience, including Spanish

july 2018

Voluntis announces the launch of Theraxium Oncology, an innovative digital platform for symptom management

july 2018

Results of the eCO trial published in the Journal of Clinical Oncology Informatics

june 2018

Voluntis and Monarch Medical Technologies announce partnership to provide seamless solution for insulin dosing across the continuum of care

may 2018

Voluntis signs contract with US payer WellDyneRx for coverage of a digital therapeutic

march 2018

Voluntis and Roche Pharma France reinvent cancer patient support with digital therapeutics

january 2018

Voluntis and WellDoc Announce Partnership to Combine Diabetes Digital Therapeutic Offerings

december 2017

Voluntis launches Insulia Savings Program, making Insulia available at $0 copay

november 2017

Voluntis to integrate Insulia® with Onduo virtual diabetes clinic

november 2017

Insulia receives FDA clearance and CE mark to integrate Basaglar and Tresiba

october 2017

Digital Therapeutics Alliance Established to Advance Novel Technologies Aimed at Transforming Patient Clinical Outcomes

july 2017

Insulia® receives FDA clearance and CE mark to integrate Toujeo®

june 2017

Voluntis and Ascensia Diabetes Care announce technology partnership to help optimize insulin management for people with Type 2 diabetes

april 2017

Voluntis adds Scott Honken to Leadership Team to strengthen payer & provider focus

march 2017

Voluntis and Sanofi announce a global alliance to deliver digital insulin titration solutions for people with type 2 diabetes

february 2017

Voluntis and Livongo Partner to Deliver Insulin Titration App

december 2016

Voluntis receives FDA clearance and CE mark for Insulia® a first for digital applications supporting type 2 diabetes patients treated with basal insulin

december 2015

Voluntis and AstraZeneca to test companion mobile app in ovarian cancer studies with the US National Cancer Institute

september 2015

Roche Pharma France and Voluntis partner to develop first therapeutic companion solution for women afflicted with breast cancer

june 2015

Voluntis announces election of Eric Elliott as Chairman of the Board of Directors

VOLUNTIS IN THE NEWS

march 2018 - FierceBiotech

Roche, Voluntis expand digital therapeutics pact into solid tumors

january 2018 - Pharmacy Practice News

Adherence Goes Hi-Tech

february 2018 - McKinsey & Company

Digital Therapeutics: Preparing for Takeoff

february 2018 - The Economist

A Revolution in Health Care is Coming

november 2017 - Pharmacy Times

Insulin Dosing Apps Are on Their Way

november 2017 - Mobihealthnews

Voluntis gets FDA clearance to add last two basal insulins to app

november 2017 - Pharmaphorum

7 questions: the Digital Therapeutic Alliance’s Pierre Leurent

november 2017 - Cancer Therapy Advisor

Mobile Apps: The Future of Cancer Care?

june 2017 - Endocrine Today

Ascensia, Voluntis to Combine Technologies

march 2017 - Close Concerns

Sanofi and Voluntis Announce Expanded Partnership

january 2017 - A Sweet Life

Insulia, Software by Prescription for Type 2 Diabetes Management

october 2016 - Les Echos

Voluntis : un leader mondial de l'e-santé

july 2016 - iMedicalApps

eCO Study App created by pharma to specifically monitor two key side effects

june 2016 - The doctor weighs in

Creating Medical Apps That Actually Get Used

BRAND ASSETS